Riskpilot← Back to searchSign inGet full accessMEDSPELAR AS
ASActiveOrg 987568585Holtegata 23, 0355 OsloActivities of trust, estate and agency accounts · NACE 6432Est. 20040 employees
Revenue 2024
NOK 1,1M
+146% vs 2023
EBITDA margin
95.6%
+160% vs 2023
Equity ratio
33.6%
Financial strength
Net profit 2024
NOK 1M
+161% vs 2023
| Revenue | NOK 1,1M | +146% |
| EBITDA | NOK 1M | +160% |
| Net profit | NOK 1M | +161% |
| Total assets | NOK 8,6M | +2% |
| Equity | NOK 2,9M | +4% |
| Employees | 0 | — |
Legal name
MEDSPELAR AS
Org number
987568585
Legal form
Aksjeselskap
NACE code
6432 · Activities of trust, estate and agency accounts
Founded
17. desember 2004
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap, styreleiar åleine eller dagleg leiar åleine.
Company purpose
Investering, herunder virksomhet som står i tilknytning til dette, samt deltakelse i andre selskaper.
Address
Holtegata 23, 0355 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2010 | 2011 | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 380 | 428 | 579 | 23 | 303 | 1 294 | 578 | 500 | 0 | 0 | 329 | 0 | 431 | 1 061 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −253 | 364 | −1 805 | −630 | −65 | −346 | 1 249 | 522 | −549 | −52 | −38 | 293 | −11 | 390 | 1 015 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −253 | 364 | −1 805 | −630 | −65 | −346 | 1 249 | 522 | −549 | −52 | −38 | 293 | −11 | 390 | 1 015 |
| Net financials | −1 039 | −86 | −89 | −425 | −405 | −413 | −491 | −591 | −495 | 73 | 88 | 79 | 28 | 1 | 5 |
| Profit before tax | −1 293 | 278 | −1 894 | −1 054 | −470 | −759 | 757 | −70 | −1 044 | 21 | 50 | 373 | 16 | 390 | 1 020 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 293 | 278 | −1 894 | −1 054 | −470 | −759 | 757 | −70 | −1 044 | 21 | 50 | 373 | 16 | 390 | 1 020 |
| Item | 2008 | 2010 | 2011 | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10 491 | 11 345 | 12 830 | 11 259 | 9 117 | 9 791 | 10 622 | 9 372 | 7 755 | 8 327 | 8 415 | 8 354 | 8 380 | 8 431 | 8 589 |
| Equity | 9 176 | 7 923 | 6 029 | 4 974 | 3 851 | 2 741 | 3 499 | 3 229 | 2 185 | 2 207 | 2 257 | 2 629 | 2 645 | 2 776 | 2 886 |
| Long-term debt | 0 | 0 | 0 | 4 061 | 4 349 | 4 532 | 4 376 | 4 608 | 5 184 | 5 584 | 5 584 | 5 584 | 5 584 | 5 584 | 5 584 |
| Short-term debt | 1 314 | 3 422 | 3 109 | 2 223 | 917 | 2 517 | 2 747 | 1 535 | 386 | 537 | 574 | 140 | 150 | 71 | 119 |
| Total debt | 1 314 | 3 422 | 6 802 | 6 284 | 5 266 | 7 049 | 7 123 | 6 143 | 5 570 | 6 121 | 6 158 | 5 724 | 5 734 | 5 655 | 5 703 |
EBITDA margin
95.6%
This company
15.8%
Market median
+505% vs market
20082024
Equity ratio
33.6%
This company
38.2%
Market median
+12% vs market
20082024
Return on equity
35.3%
This company
18.4%
Market median
+92% vs market
20082024
Net profit margin
96.1%
This company
8.1%
Market median
+1086% vs market
20082024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20082024
Debt / equity
1.98×
This company
0.62×
Market median
-219% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LK Deputy Member | Deputy Member | 2004 | — | — |
AN Chief Executive Officer | Chief Executive Officer | 2004 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDSPELAR AS 
LUMINCODE ASBoard members of MEDSPELAR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Kjetil Braute | Deputy Member | 0 companies |
| Arnstein Nordbotten | Chief Executive Officer | 0 companies |